Novadaq GmbH


Contact person: Fr. Sabrina Barre
Correspondence: Deutsch, English
Operation Level: International

Address: Sperberhorst 6
22459 Hamburg Germany
Phone: +49 40 53 87 98 22
Web: http://www.novadaq.com


NOVADAQ's global mission is to enable physicians with point-of-care imaging solutions that provide real time clinically significant and actionable information to improve care quality and lower healthcare costs. Using NOVADAQ's SPY fluorescence imaging technology, physicians can personalize therapy and achieve optimal results through the precise visualization of blood flow in vessels, micro-vessels, tissue perfusion and critical anatomical structures during the course of treatment. SPY technology enables the delivery of personalized therapies and the achievement of the optimal results for each individual patient.

More than 260 peer-reviewed publications demonstrate that the use of SPY technology will reduce post-procedure complication rates and the cost of care for a broad variety of surgical treatments for cancer, cardiovascular diseases and other conditions, helping to ensure that patients benefit from the very best possible treatment and outcome.

SPY Fluorescence Imaging Systems are United States Food and Drug Administration 510(k) cleared, Health Canada licensed, CE Marked and registered worldwide for use in multiple surgical specialities and medical applications.

The endoscopic version of SPY technology, known as PINPOINT, combines the fluorescence imaging capabilities of SPY with the high definition visible light visualization to establish a new standard in the quality and performance of minimally invasive surgery.

NOVADAQ's SPY PHI Portable Handheld Imager, combines the imaging modes of both the SPY Elite and PINPOINT systems into an easy to use point and shoot imaging platform that allows surgeons to visualize blood flow in vessels and related tissue perfusion during plastic, microsurgical, reconstructive and gastrointestinal procedures.

NOVADAQ's LUNA System is used to visualize blood flow and tissue perfusion while treating patients with atherosclerotic cardiovascular disease that impairs blood flow to the extremities and increases the risk for the development of complications such as acute and chronic non-healing wounds and limb loss.

Vertrieb medizintechnischer Geräte.

ESCP
International exhibition of coloproctology
27/09/2023 - 29/09/2023
Location LITEXPO - Lithuanian Exhibtion Centre
Vilnius (changing)
Lithuania
DCK - DEUTSCHER CHIRURGEN KONGRESS
International exhibition of general and visceral surgery
24/04/2024 - 26/04/2024
Location Congress Center Leipzig
Leipzig (changing)
Germany